Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

BiondVax Pharmaceuticals Q2 EPS $(0.10) Down From $(0.03) YoY

BiondVax Pharmaceuticals (NASDAQ:BVXV) reported quarterly losses of $(0.10) per share. This is a 233.33 percent decrease over losses of $(0.03) per share from the same period last year.
byBenzinga Newsdesk
August 26, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

BiondVax Pharmaceuticals (NASDAQ:BVXV) reported quarterly losses of $(0.10) per share. This is a 233.33 percent decrease over losses of $(0.03) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts